This retrospective study examined factors impacting refractive outcomes after combined phacoemulsification and pars plana vitrectomy (phacovitrectomy).

This retrospective study evaluated treatment of high hyperopia using LASIK with an aberration-neutral profile and large ablation zone.

This retrospective study assessed the effectiveness of Nd:YAG laser vitreolysis for vitreous floaters.

This retrospective case series evaluated the effectiveness of the hedgehog pathway inhibitor vismodegib for advanced periocular basal cell carcinoma (BCC).

This cross-sectional study compared the diagnostic accuracy of a smartphone-based artificial intelligence system versus ophthalmologist judgement for retinopathy screening in patients with diabetes.

The authors retrospectively examined the performance of recently revised diagnostic criteria for pseudotumor cerebri syndrome.

A contact lens for slowing pediatric myopia progression has received the FDA’s approval, according to manufacturer CooperVision.

This paper presents characteristics associated with adherence to annual diabetic eye exams in the United States.

This retrospective review of 2 prior toric IOL studies compared the use of intraoperative aberrometry with current-generation formulas for eyes undergoing toric IOL implantation.

This secondary analysis of the Protocol S trial compared the cost-effectiveness of ranibizumab versus laser for proliferative diabetic retinopathy.

This week, a Netflix documentary details a family’s quest to obtain the pricey gene therapy Luxturna for their child, Aldeyra’s experimental allergic conjunctivitis drug continues to impress and a young engineer may have solved a blind spot problem in cars.

This post hoc analysis of DRCR Retina Network Protocol T examined the link between changes in visual acuity and central subfield thickness in patients with diabetic macular edema (DME).

Julia A. Haller, MD, ophthalmologist-in-chief and the William Tasman, MD, Endowed Chair at Wills Eye Hospital, has been elected to the National Academy of Medicine (NAM).

This week, costume contact lenses are removed in the emergency room, Genentech’s satralizumab and Iveric’s avacincaptad pegol advance through the pipeline and a Washington ophthalmologist receives $17.2 million to study aging eyes and the brain.

This study examines the implications of suspending VEGF inhibitors for neovascular AMD when lesions have been inactive for 3 months.

This paper describes the combined use of intracorneal ring segment implantation (ICRS), phototherapeutic keratectomy (PTK) and corneal collagen cross-linking (CXL) in patients with keratoconus.

This literature review compared the safety and visual outcomes associated with optical correction using an IOL, contact lenses or spectacles after cataract surgery in children 2 years of age or younger.

This study assesses the long-term effectiveness of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma.

A corrective eyedrop for presbyopia is progressing through the regulatory pipeline as encouraging findings emerge from a phase 2b study.

This retrospective study assessed the relationship between serious immune-related adverse events during anti-PD-1 cancer therapy and tumor mutational burden.

Investigators identified patient characteristics associated with follow-up compliance after cataract surgery.

Novartis’ brolucizumab (Beovu) is now FDA approved for the treatment of wet AMD, the company reported today.

Investigators report the long-term results of accelerated corneal collagen crosslinking (CXL) treatment in adolescent patients with progressive keratoconus.

This systematic review describes the efficacy of conventional and biologic disease-modifying antirheumatic drugs in IgG4-related orbital disease.

This review describes the clinical features that distinguish between major immune-mediated and inflammatory syndromes affecting the brainstem, many of which have ophthalmic effects.